PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of scirepAboutEditorial BoardFor AuthorsScientific Reports
 
Sci Rep. 2017; 7: 10775.
Published online 2017 September 7. doi:  10.1038/s41598-017-10908-8
PMCID: PMC5589848

BMP-2 induced Dspp transcription is mediated by Dlx3/Osx signaling pathway in odontoblasts

Abstract

Dentin sialophosphoprotein (Dspp) as a differentiation marker of odontoblasts is regulated by BMP-2. However, the intimate mechanism is still unknown. Transcription factors Dlx3 and Osx are essential for odontoblasts differentiation. We hypothesized that BMP-2 regulation of Dspp transcription was mediated by Dlx3 and/or Osx in odontoblasts. In the present investigation, we found that BMP-2 stimulated expression and nuclear translocation of Dlx3 and Osx in odontoblasts both in vitro and in vivo. Osx was a downstream target of Dlx3 and both of them stimulated Dsp expression. Both Dlx3 and Osx were able to activate Dspp promoter from nucleotides (nt) −318 to +54 by transfections of luciferase reports containing different lengths of mouse Dspp promoters. The binding of Dlx3 and Osx with nt −318 to +54 of Dspp promoter was verified by chromatin immunoprecipitation in vivo. Two Dlx3 binding sites and one Osx binding site on Dspp promoter were found by EMSA. Furthermore, the exact biological function of these binding sites was confirmed by site-directed mutagenesis. At last, the protein-protein interaction between Dlx3 and Osx in odontoblasts was detected by co-immunoprecipitation. In conclusion, in this study we found a novel signaling pathway in which BMP-2 activates Dspp gene transcription via Dlx3/Osx pathway.

Introduction

The dentin sialophosphoprotein (Dspp) gene encodes the major non-collagenous protein in dentin matrix, which is expressed predominantly in preodontoblasts and odontoblasts and transiently in preameloblasts, and at low levels in osteoblasts14. DSPP is a highly phosphorylated protein that is cleaved into 3 proteins, dentin sialoprotein (DSP), dentin glycoprotein (DGP), and dentin phosphoprotein (DPP), immediately after secretion5, 6. DSP is the N-terminal portion of DSPP and is a 95-kDa glycoprotein that was first identified within the extracellular matrix of dentin5. DGP was identified as an 81-amino acid segment between DSP and DPP6. DPP is rich in aspartic acid and phosphoserine and binds to calcium. Therefore, DPP is strongly associated with mineral phase of dentin, acting as an important initiator and modulator of dentin apatite crystal formation, which makes DPP a specific marker for terminal differentiated odontoblasts5, 7, 8. Several human and mouse genetic studies have indicated that Dspp is important for dentin mineralization. Mutations of human DSPP gene are associated with human hereditary disorders such as dentinogenesis imperfecta type II (DGI-II), type III (DGI-III), and dentin dysplasia type II (DD-II)913. Dspp knockout mice exhibit dentin mineralization defects that are very similar to human DGI-III as well as impaired cranial bone development14, 15. These studies demonstrate that Dspp plays a crucial role in tooth development and mineralization, in particular dentinogenesis.

Bone morphogenetic proteins (BMPs) are structurally related to the transforming growth factor β (TGF-β) superfamily. Among the BMP family members, BMP-2 plays important roles during odontogenic differentiation16. Bmp-2 is initially expressed in the dental epithelial cells at embryonic day 12.5 (E12.5), then shifts to the dental mesenchymal papilla and is involved in specifying the fate of the dental mesenchymal cells at later stage of tooth development17, 18. During the late stage of tooth development, Bmp-2 becomes more intense in the terminal differentiated odontoblasts and regulates the differentiation of odontoblasts16, 19, 20. The odontoblasts do not mature properly and fail to form proper dentin with normal dentinal tubules and activate terminal differentiation with the deletion of the Bmp-2 gene in odontoblasts16. Studies have shown that Dspp in odontoblasts is regulated by BMP signaling, especially BMP-2, in vitro and in vivo 3, 21, 22. Beads socked in human recombinant BMP-2 induce the mRNA expression of Dspp, after implantation onto dental papilla in organ culture23. Dspp expression was reduced in the Bmp-2 knock out mice16. Previously we also have found that BMP-2 up-regulates Dspp transcription through its regulatory region in mouse preodontoblast cells3. However, the intimate molecular mechanisms of BMP-2 regulating Dspp transcription in preodontoblasts or odontoblasts have not been completely understood.

Transcription factors Dlx3 and Osx (or Sp7, Osterix) are essential for osteoblast and odontoblast differentiation2426. Both Dlx3 and Osx are suggested as downstream targets of BMP-2 signaling in osteogenic cells27, 28. Although both odontoblasts and osteoblasts originate from mesenchymal cells and share many physical similarities, the molecular mechanisms regulating odontoblasts differentiation are different from osteoblasts. For example, BMPs are able to stimulate expression of Runx2 in osteoblastic cells but not in odontoblasts2, 29. Whether Dlx3 and Osx mediate the BMP-2 induced Dspp expression in odontoblasts is still not known. During tooth morphogenesis, Dlx3 mRNA is initially expressed in the dental epithelium, and is later expressed in both the dental epithelium and the dental mesenchyme25. Mutations of DLX3 in human cause Tricho-Dento-Osseous (TDO) syndrome, which is an autosomal dominant disorder characterized by defects in ectodermal derivatives such as hair (kinky hair), teeth (enamel hypoplasia and taurodontism) and bone (increased bone density in cranium and long bones)3032. Deletion of Dlx3 in neural crest, from which dental mesenchyme is derived, leads to severe dentin hypoplasia and dysplasia and remarkably down-regulated Dspp expression33. During tooth development, Osx expression was initiated at dental papilla, and remained highly expressed in differentiating odontoblasts at later stages21. Previously, we found overexpression of Dlx3 or Osx in odontogenic cells induced cell differentiation and Dspp expression34, 35,while knock-down of Osx caused the down-regulation of Dsp expression36.

Based on these biological functions of Dlx3 and Osx during odontoblasts differentiation and tooth development, we hypothesized that BMP-2 regulation of Dspp transcription was mediated by Dlx3 and/or Osx signaling pathway in odontoblasts.

Results

BMP-2 stimulates expression and nuclear translocation of both Dlx3 and Osx in odontoblast cells

We first detected the expressions of Dlx3 and Osx in odontoblasts of first molars in Bmp2-cKO° d mice. With the knock-out of Bmp2 gene in odontoblasts (showed by in situ hybridization in Supplementary Fig. S1), the odontoblasts of first molars in Bmp2-cKO° d mice lost their differentiation and polarization, and accompanied with dramatically reduced expressions of Dlx3 and Osx compared with wild type mice, in which high expression of Dlx3 and Osx was seen in the nuclei of odontoblasts (Fig. 1A). Then we examined whether BMP-2 is able to induce expressions of Dlx3 and Osx in mouse pre-odontoblasts (MD10-F2). Our previous study indicated that BMP-2 (100 ng/ml) was sufficient to induce Dspp expression in MD10-F2 cells3. Therefore, a final concentration of 100 ng/ml of BMP-2 recombinant protein was added in the medium to stimulate MD10-F2 cells, and expressions of Dlx3, Osx, and Dsp were measured by Western blot. As illustrated in Fig. 1B, expression of Dlx3 was increased and reached the maximum level at 2–4 hours after BMP-2 treatment. Meanwhile, the expressions of Osx and Dsp were also up-regulated and reached the maximum level at 4–6 hours after BMP-2 treatment. All these in vivo and in vitro data indicated both Dlx3 and Osx are downstream targets of BMP-2 in odontoblasts. As transcription factors, Dlx3 and Osx, activated by BMP-2 should paly functions in nucleus. Then we detected the subcellular localization of Dlx3 and Osx after BMP-2 induction using immunofluorescence (Fig. 1C,D). In untreated cells, Dlx3 and Osx staining appeared mainly in the cytoplasm and weakly in nucleus. After induction with BMP-2, the staining of Dlx3 and Osx mainly localized into nucleus, compared to that in the untreated cells. These results suggested that BMP-2 not only stimulated expression of Dlx3, Osx and Dsp, but also induced nuclear translocation of Dlx3 and Osx in vitro and in vivo.

Figure 1
Effect of BMP-2 on expression and nuclear translocation of Dlx3, Osx in mouse preodontoblasts or odontoblasts. (A) Immunohistochemistry showed the expressions of Dlx3 (a and b) and Osx (c and d) in tooth germs of wild type (a and c) and Bmp2-cKO od (b ...

Osx is a downstream target of Dlx3 and both of them stimulate Dsp expression in MD10-F2 cells

It was reported that Osx is an explicit downstream target of Dlx5 in osteoblast-lineage cells37. Although Dlx5 and Dlx3 belong to the Distaless (Dlx) gene family, it is yet not known if Dlx3 is able to regulate Osx in odontoblasts. We therefore tested the relationship between Dlx3 and Osx in MD10-F2 cells. The results showed that overexpression of Dlx3 was able to induce Osx and Dsp expression (Fig. 2A), whereas overexpression of Osx only induced Dsp expression but did not influence the expression of Dlx3 (Fig. 2B). To further confirm these results, we knocked down the endogenous Dlx3 expression using Dlx3-targeted siRNA (Fig. 2C). Transfection of Dlx3 siRNA for 48 hours reduced Dlx3 expression more than 50% in MD10-F2 cells. At the same time, Osx and Dsp expression was reduced to ~40% and ~90%, respectively, compared with their expression in cells transfection with control siRNA. Thus, Osx was a downstream target of Dlx3, and both of them were able to stimulate Dsp expression in MD10-F2 cells.

Figure 2
Effect of Dlx3 and Osx on Dsp expression in MD10-F2. (A) Cells were transfected with either pcDNA3.1 or pcDNA-Dlx3 for 48 h. (B) Cells were transfected with either pcDNA3.1 or pcDNA-Osx-Flag for 48 h. (C) Cells were transfected with either ...

Dlx3 and Osx stimulate Dspp promoter activity

To confirm whether induction of Dsp expression by Dlx3 and Osx is through stimulating Dspp promoter activity, luciferase reporters containing different lengths of mouse Dspp promoters, p1318, p591, and p318, were constructed (Fig. 3A) and transiently transfected into MD10-F2 cells. Transcription activity was measured when transfected with pcDNA-Dlx3, or pcDNA-Osx-Flag, or pcDNA3.1 empty vector (Fig. 3B). Both Dlx3 and Osx failed to change the transcription activity of p1318, p591, and pGL3-Basic, compared with transfection with pcDNA 3.1 empty vector. However, overexpression of Dlx3 or Osx significantly increased the transcription activity of p318, which indicated both Dlx3 and Osx were able to stimulate Dspp promoter activity from nucleotides (nt) −318 to +54.

Figure 3
Dlx3 and Osx stimulate Dspp promoter activity. (A) Schematic illustration of the constructs used in the luciferase (Luc) assay. (B) Luciferase reporter assay showed Dlx3 and Osx enhanced p318 promoter activity, but did not influence the activities of ...

To further detect whether Dlx3 and Osx bind with the nt −318 to +54 of Dspp promoter, we performed ChIP assay. The immunoprecipitated and purified DNA was used as a template. The PCR amplifying bands with primers corresponding to the 5′-flanking region (from nt −318 to +54) of mouse Dspp gene were detected, and the band is more intense in cells transfected with pcDNA-Dlx3 or pcDNA-Osx-Flag plasmids (Fig. 3C, lanes 1–4, upper). Positive control was done using anti-TFIIB antibody to amplify GAPDH promoter (Fig. 3C, lane 5), and negative control was set using negative control IgG (Fig. 3C, lane 6). These results indicated that Dlx3 and Osx are able to directly bind to Dspp promoter region from nt −318 to +54 in vivo.

Identification of Dlx3 and Osx binding sites in the mouse Dspp promoter

It is well known Dlx3 binds to a conserved sequence of TAATT38, and Osx recognizes GC-rich sequence39. Analysis of the 5′-flanking region from nt −318 to +54 of the mouse Dspp gene showed two putative Dlx3 binding sites (Dlx3I and Dlx3II) and one putative Osx binding sites using computer software program and these sequences are highly conserved in several species, including mouse, human and rat (Fig. 4A). First, we examined whether Dlx3 and Osx could bind to their binding sites in the Dspp promoter using EMSA. The following oligonucleotide probes were prepared: Dlx3I Olig ° (−232/−212) and Dlx3II Oligo (−76/−55) covering the Dlx3I and Dlx3II binding sites, Osx Oligo (−154/−132) covering the Osx binding site on Dspp promoter. After incubation, the complexes representing protein-probe binding were detected (Fig. 4B, lanes 1, 6, and 10; Fig. 4C, lanes 1 and 5, black arrow). To confirm the specificity of the complex, 100-fold unlabeled cold probes were included into the reaction and substantially competed with the binding complex (Fig. 4B, lanes 3–5, 8, 9, 12, and 13; Fig. 4C, lanes 3, 4, 7, and 8). To confirm the identity of the specifically shifted protein, anti-Dlx3 or anti-Osx antibodies were used. When the antibodies were included in the binding reaction, super-shift representing antibody-protein-probe complexes were detected (Fig. 4B, lanes 2, 7, and 11; Fig. 4C, lane 2 and 5, white arrow). These results indicated Dlx3 and Osx were able to bind to their corresponding binding sites on the Dspp promoter in vitro.

Figure 4
Identification of Dlx3 and Osx-binding sites in the Dspp promoter in vitro. (A) Highly homogeneity of the 5′-flanking region from −318 to +54 of the Dspp gene in mouse, human and rat. The putative Dlx3 and Osx binding sites are highlighted ...

Dlx3 and Osx depend on each other to increase Dspp promoter activity

To further confirm the functional effect of Dlx3 and Osx binding sites in the mouse Dspp promoter, we generated three p318 mutant constructs with deletion of Dlx3 or Osx binding sites (Fig. 5A and andB):B): p318(Dlx3I Del), p318(Dlx3II Del), and p318(Osx Del). Then p318 or p318 mutant constructs were transiently transfected into MD10F-2 cells, and their transcription activity was evaluated with the co-transfection of pcDNA-Dlx3 and/or pcDNA-Osx-Flag. The results showed that deletion of either Dlx3I or Osx binding site suppressed the p318 response to both Dlx3 and Osx, but deletion of Dlx3II binding site only suppressed the p318 response to Dlx3 but not to Osx (Fig. 5C). These results indicated that Dlx3 activating Dspp promoter requires Osx binding to its binding site on Dspp promoter, meanwhile Osx activating Dspp promoter also requires Dlx3 binding to its binding site. In particular, binding of Dlx3 to Dlx3I element is necessary for Osx to activate p318 Dspp promoter.

Figure 5
Biological activity of the Dlx3 and Osx in mouse Dspp promoter and protein interactions between Dlx3 and Osx. (A) Illustration of core sequences of Dlx3I, Dlx3II and Osx binding elements. (B) Illustration of wild type and mutant p318 luciferase reporter ...

Dlx3 binds to Osx forming a protein complex

The result that Dlx3I element is necessary for Osx activating p318 transcription activity implied that Dlx3 may bind to Osx forming a complex to regulate Dspp transcription. Then, the protein-protein interaction between Dlx3 and Osx was detected with co-immunoprecipitation. As anticipated, Dlx3 was detected in the immunoprecipitation complex by Western blot with anti-Osx antibody as IP antibody (Fig. 5D, left penal). Meanwhile, Osx was also detected in the immunoprecipitation complex with anti-Dlx3 antibody as IP antibody (Fig. 5D, right penal), which indicated Dlx3 bound to Osx forming protein complex.

Discussion

Odontoblast differentiation is regulated by many transcription and growth factors. BMP-2 signaling induces dental mesenchymal cell differentiation into odontoblasts40. Dspp has been characterized as a unique marker of odontoblasts differentiation1, 2. It has been reported that BMP-2 is able to induce Dspp expression, but up to now, the molecular mechanisms by which BMP-2 induces Dspp transcription have not been well elucidated. The present investigation reveals a new signaling pathway, which participates in the regulation of Dspp expression by BMP-2 in odontoblasts.

Dlx3 contains a homeodomain, which is related to the distal-less domain of Drosophila and was detected even in structures involving epithelial-mesenchymal interaction, such as tooth germs and hair follicles. BMP-2 was able to induce Dlx3 gene expression in several tissue cells, including osteoblasts27, keratinocytes41, and dental follicle cells42. In addition to Dlx3, two other members of the distal-less family, Dlx2 and Dlx5, are also regulated by BMP-2 in osteogenic or chondrogenic cells27, 43. Osx as a transcription factor was first identified in C2C12 myogenic cells treated with BMP-239. Besides,it has also been reported that Osx was induced with BMP-2 in mouse progenitor cells and chondrocytes39, 44, human and mouse mesenchymal stem cells45, 46. Consistent with these previous investigations, we also demonstrated that Dlx3 and Osx were BMP-2-inducable in odontoblasts both in vitro and in vivo. Previously, an Osx-GFP fusing protein reporter system was constructed to track Osx translocation in osteogenic cells47. Osx remained mostly inactive in the cytosol of non-osteogenic cells and was activated and translocated into the nucleus with the osteogenic differentiation of osteogenic cells47. In the present investigation, as showed by immunofluorescence staining, we found both Dlx3 and Osx were activated and translocated into nucleus from cytoplasm with addition of BMP-2 in vitro and in vivo.

Although Osx mRNA expression is stimulated by BMP-2 treatment, pretreatment with cycloheximide, a protein synthesis inhibitor, blocks the BMP-2-induced expression of Osx mRNA37, which indicates that Osx is not the direct target of the BMP signaling cascade and the expression of Osx induced by BMP-2 requires the intermediation of newly synthesized proteins. In contrast to Osx expression induced by BMP-2, BMP-2-induced Dlx5 expression is unaffected by cycloheximide pretreatment48, 49, which means Dlx5 is a direct target of BMP signaling. Moreover, inhibition of Dlx5 expression blocked Osx expression50, indicating Osx is down stream target of Dlx5. In the present investigation, we found the similar results: overexpression of Dlx3 was able to induce Osx expression, but overexpression of Osx did not influence the expression of Dlx3. Furthermore, down-regulated Osx expression in cell with transfection of Dlx3-targeted siRNA further confirmed Osx is a downstream target of Dlx3 in odontoblasts. The fact that the time of Dlx3 to reach the maximum level after BMP-2 treatment is earlier than that of Osx indicates that Osx is also not the direct target of the BMP-2 in odontoblasts.

Both positive and negative regulatory mechanisms are required for the spatial and temporal expression of Dspp gene. Many investigations characterized mouse and rat Dspp gene promoters and found inverted TATA and CAATT box sequences, Sp1, Nrf1, C/EBP and Runx2 binding sites, as well as several homeodomain (Dlx and Msx) motifs in the proximal regions8, 5153. Previously, we found BMP-2 regulates Dspp expression through the activation of the heterotrimeric transcription factor NF-Y, and NF-Y binds to a BMP-2 response element in the mouse Dspp promoter, especially between nt −97 and −723. In the present investigation, we found that in addition to NF-Y, BMP-2 also regulates Dspp expression also through the Dlx3 and Osx binding sites on Dspp promoter. Two Dlx3 binding sites (DLX3I, DLX3II) and one Osx binding site were identified in the proximal mouse Dspp promoter that mediates BMP-2-stimulated Dspp expression. EMSA and ChIP analyses verified that Dlx3 and Osx bind to their target sites in the mouse Dspp promoter. To further evaluated the function of these binding sequences, direct deletion in the Dspp promoter was used, and showed that deletion of either Dlx3 or Osx binding site decreased Dspp promoter activity in MD10-F2 cells, which means each Dlx3 or Osx binding site in the Dspp promoter was functional. Duverger et al.33 demonstrated the direct binding of Dlx3 to Dspp promoter, which is in consistent with our findings. In distal-less family, Dlx5 also mediates Dspp expression regulated by BMP signal22. Although both Dlx3 and Dlx5 can bind to TAAT box, but the two Dlx3 binding sites found in the present research only respond to Dlx3 but not to Dlx522, which indicates Dlx3 and Dlx5, as distal-less family members, show different mechanism in regulation of Dspp transcription. Both Dlx3 and Osx can increase the promoter activity of p318, but not p591 and p1318. One possibility is that there are Dlx3 and Osx binding sites at upstream of nt −318 on Dspp promoter, but Dlx3 and Osx act as suppressors when binding to these binding sites. Another possibility is that there are strong negative regulatory elements for the binding of other transcription factors at upstream of nt −318 on Dspp promoter, and Dlx3 and Osx as co-factors could increase the suppressing activity of these elements. Cao et al.22 found that deletion of the region from −791 to −427 strongly increased basal Dspp promoter activity, and inferred there might be a strong negative regulatory element between nt −794 and −427. Narayanan et al.8 also identified a repression domain between nt −700 and −400 of Dspp promoter. Further analysis of this region identified two binding elements, which have 90% homology to the DNA binding sites for two bZIP transcription factors, Nrf1 and the CCAAT enhancer-binding protein (C/EBP) β. A possible response element for Yy1, a negative transcription factor, was also found (at position of nt −622) in this repression region of Dspp promoter, and the basal promoter activity of Dspp increased after the Yy1 binding sites was deleted22.

By means of co-immunoprecipitation assay we have clearly demonstrated that Dlx3 associates and functionally cooperates with Osx during regulation of Dspp transcription. Mutational studies suggest that the Dlx3 and Osx depend on each other to increase Dspp promoter activity. Dlx3 could not activate the promoter activity by binding itself to the Dspp promoter containing the mutated Osx binding site. All these results indicate the bindings of Dlx3 and Osx to their binding sites on Dspp promoter are necessary for each of these two transcription factors to activate Dspp promoter.

In conclusion, in this study we provide the evidence that BMP-2 activates Dspp gene transcription via Dlx3/Osx signaling pathway: BMP-2 interacting with its receptor on cell membrane induces Dlx3 expression, then Dlx3 induces Osx expression; subsequently, both Dlx3 and Osx are activated, enter nucleus and bind to their target sites in Dspp promoter; then Dlx3 interacts with Osx and synergistically stimulate Dspp transcription.

Methods

Animals and Tissue Preparation

All experimental procedures involving the use of animals were reviewed and approved by the Institutional Animal Care at the University of Texas Health Science Center at San Antonio. All experiments were performed in accordance with the relevant guidelines and regulations. The generations of Bmp2 f/f and 3.6Col1a1-Cre mice have been described previously54, 55. To conditionally knock out Bmp2 gene in odontoblasts, 3.6Col1a1-Cre;Bmp2 f/f (referred to as Bmp2-cKO od) mice were generated by crossing 3.6Col1a1-Cre;Bmp2 f/+ allele with Bmp2 f/f allele. Mice at postnatal day 3 (P3) were put to death. Mandibles of the mice were immediately dissected and fixed with 4% paraformaldehyde (PFA) for 24 hours at 4 °C. After washes with PBS, samples were demineralized in 8% EDTA for 2 weeks. Then, the tissues were processed for paraffin embedding and sectioned at 5 µm.

Cell Culture and Treatment

A mouse immortalized preodontoblast cell line, MD10-F2 was used56. Cells were grown at 33 °C under 5% CO2 in alpha minimum essential medium (α-MEM) supplemented with 10% fetal bovine serum, 100 units/ml penicillin/streptomycin, 50 µg/ml ascorbic acid and 10 mM sodium β-glycerophosphate. For BMP-2 induction, cells were starved overnight in FBS-free medium, then cells were induced with 100 ng/ml of recombinant human BMP-2 protein (R&D) for the indicated times. Then the cells were subjected to Western blot or immunofluorescence staining.

Immunohistochemistry and Immunofluorescence Staining

The expressions of Dlx3 and Osx in mandibular first molars of both wild type and Bmp2-cKO od mice were analyzed by immunohistochemistry as described previously57. MD10-F2 cells cultured on glass slides were fixed with cold methanol/acetone (1:1) for 10 minutes and permeabilized with 0.5% Triton-X for 15 minutes. To block the non-specific binding of antibodies, slides were incubated with 10% goat serum for 30 minutes, followed by primary antibodies, anti-Dlx3 (Abcam) and anti-Osx (Santa Cruz), overnight at 4oC. After washing with PBS, slides were incubated with secondary IgG antibodies conjugated to Alexa-Fluor 568 (Invitrogen) were added and incubated for 1 hour. Hoechst (Pierce) was used to stain nucleus.

Western Blot

Western blot was performed with whole cell lysates from MD10-F2 cells. Cells were washed with cold PBS and lysed with RIPA buffer (1× PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml phenylmethylsulfonyl fluoride, 30 μl/ml aprotinin, 100 mM sodium orthovanadate). Proteins (40 μg/well) were resolved by 10% SDS-PAGE and transferred to a Trans-blot membrane (Bio-Rad). Western blot was performed as described earlier2. Anti-Dlx3, anti-Osx, and anti-Dsp (Santa Cruz) was used as primary antibodies. β-actin antibody (Santa Cruz) was used as a loading control.

Construction of Reporter Gene Constructs, Expression Plasmids, and Mutagenesis

All reporter gene constructs containing 5′ deletions of the Dspp promoter were generated using standard cloning procedures as described previously58. Briefly, the 1372-bp BglII-HindIII fragment of the mouse Dspp gene from nucleotides (nt) −1318 to +54 was cloned into the BglII and HindIII sites of pGL3-Basic luciferase vector (Promega) and designated p1318. The 646-bp EcoRI-HindIII fragment of the mouse Dspp gene from nt −591 to +54 was cloned into the EcoRI and HindIII sites of the pGL3-Basic and called p591. The 372-bp XhoI-HindIII fragment of the mouse Dspp gene from nt −318 to +54 was cloned into the XhoI and HindIII sites of pGL3-Basic vector and called p318. All these various plasmids contained part of the exon 1 noncoding region of Dspp gene.

For the generation of expression constructs, the full length of Dlx3 cDNA or Osx cDNA containing a Flag tag was subcloned into pcDNA 3.1 vector (pcDNA-Dlx3, pcDNA-Osx-Flag). All constructs were confirmed by DNA sequencing.

Site directed deletion targeting the Dlx3 and Osx binding sites in the Dspp promoter was performed using the Quickchange® II Site-Directed Mutagenesis Kit (Stratagene). Mutant plasmids, p318(Dlx3I Del), p318(Dlx3II Del), and p318(Osx Del), were generated by site-directed deletion at −228/−221, −68/−64, and −148/−143 sites of p318 construct as a template. Primers for mutant plasmids were as follows: p318(Dlx3I Del), 5′-CTTCCAGGAGCAAGTGAAAGTAAGTCTAGTCC-3′, and 5′-GGACTAGACTTACTTTCACTTGCTCCTGGAAG-3′; p318 (Dlx3II Del), 5′-GCAGTGATTGGTTGAGAATCAAACTGAATTTAAATTTCAGC-3′, and 5′-GCTGAAATTTAAATTCAGTTTGATTCTCAACCAATC ACTGC-3′; p318(Osx Del), 5′-GCGAGCGAGGGAGTCGTTATTACAGCCTC-3′, and 5′-GAGGCTGTAATAACGACTC CCTCGCTCGC-3′. All constructs were checked by DNA sequencing and purified using Plasmid Midi Kit (Qiagen).

Overexpression and RNA Interference

MD10-F2 cells were transfected with pcDNA-Dlx3 or pcDNA-Osx-Flag or empty vector using Lipofectamine 2000 transfection reagent (Invitrogen). To knock down the endogenous Dlx3 expression, small interfering RNA (siRNA) targeted mouse Dlx3 or negative control siRNA (Santa Cruz) were transfected into MD10-F2 cells at 60 nM concentration with Lipofectamine 2000. Cell lysates were collected 24 or 48 hours after transfection and protein levels of Dlx3, Osx and Dsp were analyzed by Western blot.

Luciferase reporter assay

Cell were seeded in 48-well plates and cultured overnight. Then wild-type or mutant reporter plasmids or empty pGL3-Basic plasmid and pRL-TK Renilla luciferase reporter (Promega), as well as pcDNA-Dlx3 or/and pcDNA-Osx-Flag were co-transfected into cells using the Lipofectamine 2000 for 48 hours. After that, the cells were collected and lysed in passive lysis buffer (Promega). The luciferase assay was performed using the Dual Luciferase Reporter Assay System (Promega) according to the manufacture’s protocols. Firefly and Renilla luciferase activities were qualified using the Glomax Luminometer (Promega). Firefly luciferase activities was normalized against Renilla luciferase activities. All luciferase assays were performed in triplicate at least three times.

Chromatin Immunoprecipitation (ChIP)

ChIP were performed according to the instructions provided by ChIP-ITTM kit (Active Motif). Briefly, MD10-F2 cells were co-transfected with pcDNA-Dlx3, pcDNA-Osx-Flag expression plasmids and p318 plasmid. After 72 hours of transfection, cells were washed in PBS and incubated for 10 minutes with 1% formaldehyde. After quenching the reaction with 0.1 M glycine, the cross-linked material was sonicated into chromatin fragment of an average length of 200–800 bp. After pre-cleaning, 1% of each sample was saved as input fraction. The chromatin solution was precleared by adding protein G beads with salmon sperm DNA for 2 hours at 4 °C. Then immunoprecipitations were performed with protein G beads and 5 μg of anti-Dlx3 or Osx antibodies overnight at 4 °C. Anti-TFIIB antibody and negative control IgG (all from Santa Cruz Biotechnology) were used as positive and negative controls. Immunoprecipitated materials were washed, and cross-links were reversed by incubating samples for 5 hours at 65 °C in 200 mM NaCl and 10 μg of Rnase A to eliminate RNA. Recovered material was treated with proteinase K, and the DNA fragment was purified by Qiagen columns (Qiagen). The purified DNA was analyzed by PCR amplifying promoter regions (−318/+54) of the Dspp gene using the following primer pairs: forward −3185′-GAAATGCAGGGTGACAGAGTCTAAGTGGCT-3′−289, and reverse+545′-CGAGGGG ACTTTGAAAATCCAGATT-3′+30. The sequence of positive control PCR primers was provided by the kit, which flank the GAPDH promoter. The sequence of negative control PCR primers was also provided by the kit, which flank a region of genomic DNA between the GAPDH gene and the chromosome condensation-related SMC-associated protein (CNAP1) gene.

Electrophoretic Mobility Shift Assay (EMSA)

Recombinant Dlx3 protein was purchased from Novus Biologicals. Nuclear extracts from MD 10-F2 cells were prepared using the method of Dignam et al.59. Protein concentration was determined by using the Bradford assay60. Oligonucleotides used in EMSA were synthesized as listed in Table 1. Dlx3 (Con) Oligo and Osx (Con) Oligo were set as positive control, which were verified containing two copies of the Dlx3 binding sites and one GC-rich Osx binding site, respectively39, 61. Dlx3I Oligo, Dlx3II Oligo, and Osx Oligo consist of the putative Dlx3 or Osx binding region of Dspp promoter. These oligonucleotides were labeled with [γ-32P]ATP. Double-stranded probes were generated by annealing [γ-32P]ATP—labeled complementary oligonucleotides. EMSA was performed as described previously58. For the competition binding reactions, the unlabeled competitor in 100-fold molar excesses of the labeled probe was included in the reaction. Antibody super-shift experiments were performed with anti-Dlx3 and anti-Osx antibodies. The antibodies were added to recombinant Dlx3 protein or the nuclear extracts 10 min prior to the addition of the radiolabeled prob. Free and protein-bound DNA complexes were loaded onto a 5% native polyacrylamide gel in 1 × Tris/boric acid/EDTA (TBE) buffer, electrophoresed, dried, and exposed to X-ray film.

Table 1
EMSA and competitions were performed with the oligonucleotide duplexes listed below

Co-immunoprecipitation (Co-IP) Analysis

MD10-F2 cells cultured in 10-cm dish were transfected with 10 μg of pcDNA-Dlx3 and pcDNA-Osx-Flag. After 72 hours of transfection, cells were lysed with RIPA lysis buffer, and centrifuged at 12,000 rpm at 4 °C for 20 minutes. The supernatant was collected and precleared with 40 μl of protein A/G plus agarose beads (Santa Cruz) at 4 °C for 30 minutes. Immunoprecipitation was performed with anti-Dlx3, anti-Osx, anti-Flag (Sigma) antibodies or negative control IgG (3 μg each) and immunocomplexes were precipitated with 50 μl of protein A/G plus agarose beads. Beads were washed three times with wash buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10% glycerol, 1% NP-40, and 2 mM EDTA). Protein was eluted by boiling in 50 μl of sample buffer for 10 minutes and analyzed by Western blot.

Statistical Analysis

Quantitative data were presented as means ± SD from three independent experiments and analyzed with Analysis of Variance (ANOVA) or Student’s t test with SPSS. For Western blot, densitometry of immunoblot bands were analyzed with ImageJ software.

Electronic supplementary material

Acknowledgements

This work was supported by NIH grants (DE019802) and grants from the National Nature Science Foundation of China (81371105, 81570942, and 81420108011). The authors declare no competing financial interests.

Author Contributions

Author Contributions

G.B.Y., G.H.Y, and S.C. contributed to conception, design, data acquisition, analysis, draft and critically revised the manuscript. M.M., and Z.C. contributed to interpretation, critically revised the manuscript. All authors reviewed the manuscript.

Notes

Competing Interests

The authors declare that they have no competing interests.

Footnotes

Electronic supplementary material

Supplementary information accompanies this paper at doi:10.1038/s41598-017-10908-8

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

1. D’Souza RN, et al. Gene expression patterns of murine dentin matrix protein 1 (Dmp1) and dentin sialophosphoprotein (DSPP) suggest distinct developmental functions in vivo. J. Bone Miner. Res. 1997;12:2040–2049. doi: 10.1359/jbmr.1997.12.12.2040. [PubMed] [Cross Ref]
2. Chen S, et al. Differential regulation of dentin sialophosphoprotein expression by Runx2 during odontoblast cytodifferentiation. J. Biol. Chem. 2005;280:29717–29727. doi: 10.1074/jbc.M502929200. [PubMed] [Cross Ref]
3. Chen S, et al. Bone morphogenetic protein 2 mediates dentin sialophosphoprotein expression and odontoblast differentiation via NF-Y signaling. J. Biol. Chem. 2008;283:19359–19370. doi: 10.1074/jbc.M709492200. [PMC free article] [PubMed] [Cross Ref]
4. Qin C, et al. The expression of dentin sialophosphoprotein gene in bone. J. Dent. Res. 2002;81:392–394. doi: 10.1177/154405910208100607. [PubMed] [Cross Ref]
5. MacDougall M, et al. Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by a gene on human chromosome 4. Dentin phosphoprotein DNA sequence determination. J. Biol. Chem. 1997;272:835–842. doi: 10.1074/jbc.272.2.835. [PubMed] [Cross Ref]
6. Yamakoshi Y, et al. Dentin sialophosphoprotein is processed by MMP-2 and MMP-20 in vitro and in vivo. J. Biol. Chem. 2006;281:38235–38243. doi: 10.1074/jbc.M607767200. [PubMed] [Cross Ref]
7. Butler WT. Dentin matrix proteins. Eur. J. Oral Sci. 1998;106(Suppl 1):204–210. doi: 10.1111/j.1600-0722.1998.tb02177.x. [PubMed] [Cross Ref]
8. Narayanan K, et al. The CCAAT enhancer-binding protein (C/EBP)beta and Nrf1 interact to regulate dentin sialophosphoprotein (DSPP) gene expression during odontoblast differentiation. J. Biol. Chem. 2004;279:45423–45432. doi: 10.1074/jbc.M405031200. [PubMed] [Cross Ref]
9. Xiao S, et al. Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat. Genet. 2001;27:201–204. doi: 10.1038/84848. [PubMed] [Cross Ref]
10. Zhang X, et al. DSPP mutation in dentinogenesis imperfecta Shields type II. Nat. Genet. 2001;27:151–152. doi: 10.1038/84765. [PubMed] [Cross Ref]
11. Dong J, Gu T, Jeffords L, MacDougall M. Dentin phosphoprotein compound mutation in dentin sialophosphoprotein causes dentinogenesis imperfecta type III. Am. J. Med. Genet. A. 2005;132A:305–309. doi: 10.1002/ajmg.a.30460. [PubMed] [Cross Ref]
12. Rajpar MH, et al. Mutation of the signal peptide region of the bicistronic gene DSPP affects translocation to the endoplasmic reticulum and results in defective dentine biomineralization. Hum. Mol. Genet. 2002;11:2559–2565. doi: 10.1093/hmg/11.21.2559. [PubMed] [Cross Ref]
13. Kim JW, et al. A novel splice acceptor mutation in the DSPP gene causing dentinogenesis imperfecta type II. Hum. Genet. 2004;115:248–254. [PubMed]
14. Sreenath T, et al. Dentin sialophosphoprotein knockout mouse teeth display widened predentin zone and develop defective dentin mineralization similar to human dentinogenesis imperfecta type III. J. Biol. Chem. 2003;278:24874–24880. doi: 10.1074/jbc.M303908200. [PubMed] [Cross Ref]
15. Chen Y, Zhang Y, Ramachandran A, George A. DSPP is essential for normal development of the dental-craniofacial complex. J. Dent. Res. 2016;95:302–310. doi: 10.1177/0022034515610768. [PMC free article] [PubMed] [Cross Ref]
16. Yang W, et al. Bmp2 is required for odontoblast differentiation and pulp vasculogenesis. J. Dent. Res. 2012;91:58–64. doi: 10.1177/0022034511424409. [PMC free article] [PubMed] [Cross Ref]
17. Thomadakis G, Ramoshebi LN, Crooks J, Rueger DC, Ripamonti U. Immunolocalization of bone morphogenetic protein-2 and -3 and osteogenic protein-1 during murine tooth root morphogenesis and in other craniofacial structures. Eur. J. Oral Sci. 1999;107:368–377. doi: 10.1046/j.0909-8836.1999.eos107508.x. [PubMed] [Cross Ref]
18. Lyons KM, Pelton RW, Hogan BL. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A) Development. 1990;109:833–844. [PubMed]
19. Nakashima M, Nagasawa H, Yamada Y, Reddi AH. Regulatory role of transforming growth factor-beta, bone morphogenetic protein-2, and protein-4 on gene expression of extracellular matrix proteins and differentiation of dental pulp cells. Dev. Biol. 1994;162:18–28. doi: 10.1006/dbio.1994.1063. [PubMed] [Cross Ref]
20. Nakashima M, Reddi AH. The application of bone morphogenetic proteins to dental tissue engineering. Nat. Biotechnol. 2003;21:1025–1032. doi: 10.1038/nbt864. [PubMed] [Cross Ref]
21. Chen S, et al. Runx2, osx, and dspp in tooth development. J. Dent. Res. 2009;88:904–909. doi: 10.1177/0022034509342873. [PMC free article] [PubMed] [Cross Ref]
22. Cho YD, et al. The canonical BMP signaling pathway plays a crucial part in stimulation of dentin sialophosphoprotein expression by BMP-2. J. Biol. Chem. 2010;285:36369–36376. doi: 10.1074/jbc.M110.103093. [PMC free article] [PubMed] [Cross Ref]
23. Iohara K, et al. Dentin regeneration by dental pulp stem cell therapy with recombinant human bone morphogenetic protein 2. J. Dent. Res. 2004;83:590–595. doi: 10.1177/154405910408300802. [PubMed] [Cross Ref]
24. Hassan MQ, et al. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell Biol. 2004;24:9248–9261. doi: 10.1128/MCB.24.20.9248-9261.2004. [PMC free article] [PubMed] [Cross Ref]
25. Zhao Z, Stock D, Buchanan A, Weiss K. Expression of Dlx genes during the development of the murine dentition. Dev. Genes Evol. 2000;210:270–275. doi: 10.1007/s004270050314. [PubMed] [Cross Ref]
26. Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cell. Biochem. 2006;99:1233–1239. doi: 10.1002/jcb.20958. [PubMed] [Cross Ref]
27. Hassan MQ, et al. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J. Biol. Chem. 2006;281:40515–40526. doi: 10.1074/jbc.M604508200. [PubMed] [Cross Ref]
28. Matsubara T, et al. BMP2 regulates osterix through Msx2 and Runx2 during osteoblast differentiation. J. Biol. Chem. 2008;283:29119–29125. doi: 10.1074/jbc.M801774200. [PMC free article] [PubMed] [Cross Ref]
29. Alliston T, et al. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 2001;20:2254–2272. doi: 10.1093/emboj/20.9.2254. [PubMed] [Cross Ref]
30. Price JA, Bowden DW, Wright JT, Pettenati MJ, Hart TC. Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome. Hum. Mol. Genet. 1998;7:563–569. doi: 10.1093/hmg/7.3.563. [PubMed] [Cross Ref]
31. Nieminen P, et al. DLX3 homeodomain mutations cause tricho-dento-osseous syndrome with novel phenotypes. Cells Tissues Organs. 2011;194:49–59. doi: 10.1159/000322561. [PubMed] [Cross Ref]
32. Nguyen T, Phillips C, Frazier-Bower S, Wright T. Craniofacial variations in the tricho-dento-osseous syndrome. Clin. Genet. 2013;83:375–379. doi: 10.1111/j.1399-0004.2012.01907.x. [PubMed] [Cross Ref]
33. Duverger O, et al. Neural crest deletion of Dlx3 leads to major dentin defects through down-regulation of Dspp. J. Biol. Chem. 2012;287:12230–12240. doi: 10.1074/jbc.M111.326900. [PMC free article] [PubMed] [Cross Ref]
34. Li X, Yang G, Fan M. Effects of homeobox gene distal-less 3 on proliferation and odontoblastic differentiation of human dental pulp cells. J. Endod. 2012;38:1504–1510. doi: 10.1016/j.joen.2012.07.009. [PubMed] [Cross Ref]
35. Yang G, Li X, Yuan G, Liu P, Fan M. The effects of osterix on the proliferation and odontoblastic differentiation of human dental papilla cells. J. Endod. 2014;40:1771–1777. doi: 10.1016/j.joen.2014.04.012. [PubMed] [Cross Ref]
36. Liu H, et al. miR-145 and miR-143 regulate odontoblast differentiation through targeting Klf4 and Osx genes in a feedback loop. J. Biol. Chem. 2013;288:9261–9271. doi: 10.1074/jbc.M112.433730. [PMC free article] [PubMed] [Cross Ref]
37. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 2003;309:689–694. doi: 10.1016/j.bbrc.2003.08.058. [PubMed] [Cross Ref]
38. Feledy JA, Morasso MI, Jang SI, Sargent TD. Transcriptional activation by the homeodomain protein distal-less 3. Nucleic Acids Res. 1999;27:764–770. doi: 10.1093/nar/27.3.764. [PMC free article] [PubMed] [Cross Ref]
39. Nakashima K, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108:17–29. doi: 10.1016/S0092-8674(01)00622-5. [PubMed] [Cross Ref]
40. Iohara K, et al. Side population cells isolated from porcine dental pulp tissue with self-renewal and multipotency for dentinogenesis, chondrogenesis, adipogenesis, and neurogenesis. Stem Cells. 2006;24:2493–2503. doi: 10.1634/stemcells.2006-0161. [PubMed] [Cross Ref]
41. Park GT, Morasso MI. Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes. Nucleic Acids Res. 2002;30:515–522. doi: 10.1093/nar/30.2.515. [PMC free article] [PubMed] [Cross Ref]
42. Viale-Bouroncle S, Klingelhöffer C, Ettl T, Reichert TE, Morsczeck C. A protein kinase A (PKA)/β-catenin pathway sustains the BMP2/DLX3-induced osteogenic differentiation in dental follicle cells (DFCs) Cell Signal. 2015;27:598–605. doi: 10.1016/j.cellsig.2014.12.008. [PubMed] [Cross Ref]
43. Xu SC, Harris MA, Rubenstein JL, Mundy GR, Harris SE. Bone morphogenetic protein-2 (BMP-2) signaling to the Col2alpha1 gene in chondroblasts requires the homeobox gene Dlx-2. DNA Cell Biol. 2001;20:359–365. doi: 10.1089/10445490152122479. [PubMed] [Cross Ref]
44. Yagi K, et al. Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J. Cell. Biochem. 2003;88:1077–1083. doi: 10.1002/jcb.10467. [PubMed] [Cross Ref]
45. Biver E, Thouverey C, Magne D, Caverzasioa J. Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells. Mol. Cell. Endocrinol. 2014;382:120–130. doi: 10.1016/j.mce.2013.09.018. [PubMed] [Cross Ref]
46. Hosogane N, et al. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int. J. Biochem. Cell Biol. 2010;42:1132–1141. doi: 10.1016/j.biocel.2010.03.020. [PMC free article] [PubMed] [Cross Ref]
47. Tai G, Christodoulou I, Bishop AE, Polak JM. Use of green fluorescent fusion protein to track activation of the transcription factor osterix during early osteoblast differentiation. Biochem. Biophys. Res. Commun. 2005;333:1116–1122. doi: 10.1016/j.bbrc.2005.05.195. [PubMed] [Cross Ref]
48. Lee MH, et al. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J. Cell. Biochem. 1999;73:114–125. doi: 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.0.CO;2-M. [PubMed] [Cross Ref]
49. Lee MH, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J. Biol. Chem. 2003;278:34387–34394. doi: 10.1074/jbc.M211386200. [PubMed] [Cross Ref]
50. Ryoo HM, Lee MH, Kim YJ. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene. 2006;366:51–57. doi: 10.1016/j.gene.2005.10.011. [PubMed] [Cross Ref]
51. Feng JQ, et al. Genomic organization, chromosomal mapping, and promoter analysis of the mouse dentin sialophosphoprotein (Dspp) gene, which codes for both dentin sialoprotein and dentin phosphoprotein. J. Biol. Chem. 1998;273:9457–9464. doi: 10.1074/jbc.273.16.9457. [PubMed] [Cross Ref]
52. Ritchie HH, Li XR, Hanks CT, Knudtson K, Wang LH. The conservation and regulation of rat DSP-PP gene. Connect. Tissue Res. 2002;43:331–337. doi: 10.1080/03008200290001041. [PubMed] [Cross Ref]
53. Chen S, et al. Spatial expression of Cbfa1/Runx2 isoforms in teeth and characterization of binding sites in the DSPP gene. Connect. Tissue Res. 2002;43:338–344. doi: 10.1080/03008200290000691. [PubMed] [Cross Ref]
54. Yang W, et al. Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J. Cell Sci. 2013;126:4085–4098. doi: 10.1242/jcs.118596. [PubMed] [Cross Ref]
55. Liu F, et al. Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int. J. Dev. Biol. 2004;48:645–653. doi: 10.1387/ijdb.041816fl. [PubMed] [Cross Ref]
56. MacDougall M, et al. Temperature sensitive simian virus 40 large T antigen immortalization of murine odontoblast cell cultures: establishment of clonal odontoblast cell line. Connect. Tissue Res. 1995;33:97–103. doi: 10.3109/03008209509016988. [PubMed] [Cross Ref]
57. Yuan G, Yang G, Song G, Chen Z, Chen S. Immunohistochemical localization of the NH(2)-terminal and COOH-terminal fragments of dentin sialoprotein in mouse teeth. Cell Tissue Res. 2012;349:605–614. doi: 10.1007/s00441-012-1418-4. [PMC free article] [PubMed] [Cross Ref]
58. Chen S, et al. Regulation of the cell type-specific dentin sialophosphoprotein gene expression in mouse odontoblasts by a novel transcription repressor and an activator CCAAT-binding factor. J. Biol. Chem. 2004;279:42182–42191. doi: 10.1074/jbc.M402476200. [PubMed] [Cross Ref]
59. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475–1489. doi: 10.1093/nar/11.5.1475. [PMC free article] [PubMed] [Cross Ref]
60. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [PubMed] [Cross Ref]
61. Duverger O, et al. Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome. J. Biol. Chem. 2008;283:20198–20208. doi: 10.1074/jbc.M709562200. [PMC free article] [PubMed] [Cross Ref]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group